Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Receivables (2017 - 2025)

Neuronetics (STIM) has disclosed Receivables for 9 consecutive years, with $17.5 million as the latest value for Q4 2025.

  • Quarterly Receivables fell 30.74% to $17.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.5 million through Dec 2025, down 30.74% year-over-year, with the annual reading at $17.5 million for FY2025, 30.74% down from the prior year.
  • Receivables for Q4 2025 was $17.5 million at Neuronetics, down from $18.7 million in the prior quarter.
  • The five-year high for Receivables was $27.0 million in Q2 2025, with the low at $7.0 million in Q1 2021.
  • Average Receivables over 5 years is $15.5 million, with a median of $15.7 million recorded in 2022.
  • The sharpest move saw Receivables surged 97.75% in 2022, then plummeted 30.74% in 2025.
  • Over 5 years, Receivables stood at $7.7 million in 2021, then skyrocketed by 97.75% to $15.2 million in 2022, then grew by 8.78% to $16.6 million in 2023, then soared by 52.53% to $25.3 million in 2024, then tumbled by 30.74% to $17.5 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $17.5 million, $18.7 million, and $27.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.